We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers
News

Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers

Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers
News

Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Illumina has announced that the Genomic Medicine Institute (GMI) at Seoul National University College of Medicine in Korea, purchased seven additional Illumina Genome AnalyzerIIx sequencing systems, expanding the capacity of their recently established Asian Genome Center to 10 Illumina sequencing systems.

“GMI’s decision to add seven additional Genome Analyzers is further validation that our sequencing platform is delivering leading performance with its unmatched rate of daily output, ease of use and proven paired-end sequencing capabilities,” said Tim Orpin, general manager of Illumina’s Asia Pacific Region.

Dr. Jeong-Sun Seo, director of the Genomic Medicine Institute, and his team, have completed a deep sequencing project of the Korean genome and the work was published online in Nature July 8, 2009. “This publication demonstrates the global competitiveness of GMI’s technological capabilities and provides a practical example of Korean bio-medical excellence,” said Dr. Seo.
Advertisement